{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T22:29:32Z","timestamp":1776205772331,"version":"3.50.1"},"reference-count":114,"publisher":"The Society for Free Radical Research Japan","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Biochem. Nutr."],"published-print":{"date-parts":[[2020,3,1]]},"DOI":"10.3164\/jcbn.19-119","type":"journal-article","created":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T22:04:55Z","timestamp":1581631495000},"page":"83-91","source":"Crossref","is-referenced-by-count":43,"title":["Reactive oxygen species in cardiovascular health and disease: special references to nitric oxide, hydrogen peroxide, and Rho-kinase"],"prefix":"10.3164","volume":"66","author":[{"given":"Hiroaki","family":"Shimokawa","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1739","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Shimokawa H. 2014 Williams Harvey Lecture: importance of coronary vasomotion abnormalities\u2014from bench to bedside. Eur Heart J 2014; 35: 3180\u20133193.","DOI":"10.1093\/eurheartj\/ehu427"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Vanhoutte PM, Shimokawa H, Feletou M, Tang EH. Endothelial dysfunction and vascular disease\u2014a 30th anniversary update. Acta Physiol (Oxf) 2017; 219: 22\u201396.","DOI":"10.1111\/apha.12646"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Feletou M, Vanhoutte PM. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol 1988; 93: 515\u2013524.","DOI":"10.1111\/j.1476-5381.1988.tb10306.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Chen G, Suzuki H, Weston AH. Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels. Br J Pharmacol 1988; 95: 1165\u20131174.","DOI":"10.1111\/j.1476-5381.1988.tb11752.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Shimokawa H, Yasutake H, Fujii K, et al. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol 1996; 28: 703\u2013711.","DOI":"10.1097\/00005344-199611000-00014"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Matsui T, Amano M, Yamamoto T, et al. Rho-associated kinase, a novel serine\/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J 1996; 15: 2208\u20132216.","DOI":"10.1002\/j.1460-2075.1996.tb00574.x"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Leung T, Chen XQ, Manser E, Lim L. The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol Cell Biol 1996; 16: 5313\u20135327.","DOI":"10.1128\/MCB.16.10.5313"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Ishizaki T, Maekawa M, Fujisawa K, et al. The small GTP-binding protein Rho binds to and activates a 160 kDa Ser\/Thr protein kinase homologous to myotonic dystrophy kinase. EMBO J 1996; 15: 1885\u20131893.","DOI":"10.1002\/j.1460-2075.1996.tb00539.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Kimura K, Ito M, Amano M, et al. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 1996; 273: 245\u2013248.","DOI":"10.1126\/science.273.5272.245"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Amano M, Ito M, Kimura K, et al. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 1996; 271: 20246\u201320249.","DOI":"10.1074\/jbc.271.34.20246"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Godo S, Sawada A, Saito H, et al. Disruption of physiological balance between nitric oxide and endothelium-dependent hyperpolarization impairs cardiovascular homeostasis in mice. Arterioscler Thromb Vasc Biol 2016; 36: 97\u2013107.","DOI":"10.1161\/ATVBAHA.115.306499"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Urakami-Harasawa L, Shimokawa H, Nakashima M, Egashira K, Takeshita A. Importance of endothelium-derived hyperpolarizing factor in human arteries. J Clin Invest 1997; 100: 2793\u20132799.","DOI":"10.1172\/JCI119826"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 F\u00e9l\u00e9tou M, Vanhoutte PM. EDHF: an update. Clin Sci (Lond) 2009; 117: 139\u2013155.","DOI":"10.1042\/CS20090096"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Ozkor MA, Murrow JR, Rahman AM, et al. Endothelium-derived hyperpolarizing factor determines resting and stimulated forearm vasodilator tone in health and in disease. Circulation 2011; 123: 2244\u20132253.","DOI":"10.1161\/CIRCULATIONAHA.110.990317"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Ohashi J, Sawada A, Nakajima S, Noda K, Takaki A, Shimokawa H. Mechanisms for enhanced endothelium-derived hyperpolarizing factor-mediated responses in microvessels in mice. Circ J 2012; 76: 1768\u20131779.","DOI":"10.1253\/circj.CJ-12-0197"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 1996; 78: 415\u2013423.","DOI":"10.1161\/01.RES.78.3.415"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Fisslthaler B, Popp R, Kiss L, et al. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 1999; 401: 493\u2013497.","DOI":"10.1038\/46816"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Griffith TM, Chaytor AT, Edwards DH. The obligatory link: role of gap junctional communication in endothelium-dependent smooth muscle hyperpolarization. Pharmacol Res 2004; 49: 551\u2013564.","DOI":"10.1016\/j.phrs.2003.11.014"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Edwards G, Dora KA, Gardener MJ, Garland CJ, Weston AH. K<sup>+<\/sup> is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 1998; 396: 269\u2013272.","DOI":"10.1038\/24388"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Matoba T, Shimokawa H, Nakashima M, et al. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest 2000; 106: 1521\u20131530.","DOI":"10.1172\/JCI10506"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Shimokawa H. Hydrogen peroxide as an endothelium-derived hyperpolarizing factor. Pflugers Arch 2010; 459: 915\u2013922.","DOI":"10.1007\/s00424-010-0790-8"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Matoba T, Shimokawa H, Kubota H, et al. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in human mesenteric arteries. Biochem Biophys Res Commun 2002; 290: 909\u2013913.","DOI":"10.1006\/bbrc.2001.6278"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Miura H, Bosnjak JJ, Ning G, Saito T, Miura M, Gutterman DD. Role for hydrogen peroxide in flow-induced dilation of human coronary arterioles. Circ Res 2003; 92: e31\u2013e40.","DOI":"10.1161\/01.RES.0000054200.44505.AB"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Matoba T, Shimokawa H, Morikawa K, et al. Electron spin resonance detection of hydrogen peroxide as an endothelium-derived hyperpolarizing factor in porcine coronary microvessels. Arterioscler Thromb Vasc Biol 2003; 23: 1224\u20131230.","DOI":"10.1161\/01.ATV.0000078601.79536.6C"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Yada T, Shimokawa H, Hiramatsu O, et al. Hydrogen peroxide, an endogenous endothelium-derived hyperpolarizing factor, plays an important role in coronary autoregulation <i>in vivo<\/i>. Circulation 2003; 107: 1040\u20131045.","DOI":"10.1161\/01.CIR.0000050145.25589.65"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Yada T, Shimokawa H, Hiramatsu O, et al. Cardioprotective role of endogenous hydrogen peroxide during ischemia-reperfusion injury in canine coronary microcirculation <i>in vivo<\/i>. Am J Physiol 2006; 291: H1138\u2013H1146.","DOI":"10.1152\/ajpheart.00187.2006"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Yada T, Shimokawa H, Hiramatsu O, et al. Important role of endogenous hydrogen peroxide in pacing-induced metabolic coronary vasodilation in dogs <i>in vivo<\/i>. J Am Coll Cardiol 2007; 50: 1272\u20131278.","DOI":"10.1016\/j.jacc.2007.05.039"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Liu Y, Bubolz AH, Mendoza S, Zhang DX, Gutterman DD. H<sub>2<\/sub>O<sub>2<\/sub> is the transferrable factor mediating flow-induced dilation in human coronary arterioles. Circ Res 2011; 108: 566\u2013573.","DOI":"10.1161\/CIRCRESAHA.110.237636"},{"key":"29","unstructured":"29 F\u00e9l\u00e9tou M. The Endothelium: Part 2: EDHF-Mediated Responses \u201cThe Classical Pathway\u201d. San Rafael, CA: Morgan &amp; Claypool Life Sciences Publisher, 2011."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Russo G, Di Franco A, Lamendola P, et al. Lack of effect of nitrates on exercise stress test results in patients with microvascular angina. Cardiovasc Drugs Ther 2013; 27: 229\u2013234.","DOI":"10.1007\/s10557-013-6439-z"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Redfield MM, Anstrom KJ, Levine JA, et al. Isosorbide mononitrate in heart failure with preserved ejection fraction. N Engl J Med 2015; 373: 2314\u20132324.","DOI":"10.1056\/NEJMoa1510774"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Takahashi J, Nihei T, Takagi Y, et al. Prognostic impact of chronic nitrate therapy in patients with vasospastic angina: multicentre registry study of the Japanese coronary spasm association. Eur Heart J 2015; 36: 228\u2013237.","DOI":"10.1093\/eurheartj\/ehu313"},{"key":"33","unstructured":"33 Golino M, Spera FR, Manfredonia L, et al. Microvascular ischemia in patients with successful percutaneous coronary intervention: effects of ranolazine and isosorbide-5-mononitrate. Eur Rev Med Pharmacol Sci 2018; 22: 6545\u20136550."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Vanhoutte PM. Endothelium-derived free radicals: for worse and for better. J Clin Invest 2001; 107: 23\u201325.","DOI":"10.1172\/JCI11832"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Prysyazhna O, Rudyk O, Eaton P. Single atom substitution in mouse protein kinase G eliminates oxidant sensing to cause hypertension. Nat Med 2012; 18: 286\u2013290.","DOI":"10.1038\/nm.2603"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Nakajima S, Ohashi J, Sawada A, Noda K, Fukumoto Y, Shimokawa H. Essential role of bone marrow for microvascular endothelial and metabolic functions in mice. Circ Res 2012; 111: 87\u201396.","DOI":"10.1161\/CIRCRESAHA.112.270215"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Reddi AR, Culotta VC. SOD1 integrates signals from oxygen and glucose to repress respiration. Cell 2013; 152: 224\u2013235.","DOI":"10.1016\/j.cell.2012.11.046"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Holmstr\u00f6m KM, Finkel T. Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat Rev Mol Cell Biol 2014; 15: 411\u2013421.","DOI":"10.1038\/nrm3801"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Shimokawa H, Morikawa K. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in animals and humans. J Mol Cell Cardiol 2005; 39: 725\u2013732.","DOI":"10.1016\/j.yjmcc.2005.07.007"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Rubanyi GM, Vanhoutte PM. Oxygen-derived free radicals, endothelium, and responsiveness of vascular smooth muscle. Am J Physiol 1986; 250 (5 Pt 2): H815\u2013H821.","DOI":"10.1152\/ajpheart.1986.250.5.H815"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Nagao T, Illiano S, Vanhoutte PM. Calmodulin antagonists inhibit endothelium- dependent hyperpolarization in the canine coronary artery. Br J Pharmacol 1992; 107: 382\u2013386.","DOI":"10.1111\/j.1476-5381.1992.tb12755.x"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Lacza Z, Puskar M, Kis B, Perciaccante JV, Miller AW, Busija DW. Hydrogen peroxide acts as an EDHF in the piglet pial vasculature in response to bradykinin. Am J Physiol Heart Circ Physiol 2002; 283: H406\u2013H411.","DOI":"10.1152\/ajpheart.00007.2002"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Burgoyne JR, Oka S, Ale-Agha N, Eaton P. Hydrogen peroxide sensing and signaling by protein kinases in the cardiovascular system. Antioxid Redox Signal 2013; 18: 1042\u20131052.","DOI":"10.1089\/ars.2012.4817"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Takaki A, Morikawa K, Murayama Y, et al. Roles of endothelial oxidases in endothelium-derived hyperpolarizing factor responses in mice. J Cardiovasc Pharmacol 2008; 52: 510\u2013517.","DOI":"10.1097\/FJC.0b013e318190358b"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Takaki A, Morikawa K, Tsutsui M, et al. Crucial role of nitric oxide synthases system in endothelium-dependent hyperpolarization in mice. J Exp Med 2008; 205: 2053\u20132063.","DOI":"10.1084\/jem.20080106"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Shimokawa H, Godo S. Diverse functions of endothelial NO synthases system: NO and EDH. J Cardiovasc Pharmacol 2016; 67: 361\u2013366.","DOI":"10.1097\/FJC.0000000000000348"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Godo S, Shimokawa H. Divergent roles of endothelial nitric oxide synthases system in maintaining cardiovascular homeostasis. Free Radic Biol Med 2017; 109: 4\u201310.","DOI":"10.1016\/j.freeradbiomed.2016.12.019"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Morikawa K, Shimokawa H, Matoba T, et al. Pivotal role of Cu,Zn-superoxide dismutase in endothelium-dependent hyperpolarization. J Clin Invest 2003; 112: 1871\u20131879.","DOI":"10.1172\/JCI200319351"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49 Liu Y, Zhao H, Li H, Kalyanaraman B, Nicolosi AC, Gutterman DD. Mitochondrial sources of H<sub>2<\/sub>O<sub>2<\/sub> generation play a key role in flow-mediated dilation in human coronary resistance arteries. Circ Res 2003; 93: 573\u2013580.","DOI":"10.1161\/01.RES.0000091261.19387.AE"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50 Larsen BT, Bubolz AH, Mendoza SA, Pritchard KA Jr, Gutterman DD. Bradykinin-induced dilation of human coronary arterioles requires NADPH oxidase-derived reactive oxygen species. Arterioscler Thromb Vasc Biol 2009; 29: 739\u2013745.","DOI":"10.1161\/ATVBAHA.108.169367"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51 Sartoretto JL, Kalwa H, Pluth MD, Lippard SJ, Michel T. Hydrogen peroxide differentially modulates cardiac myocyte nitric oxide synthesis. Proc Natl Acad Sci U S A 2011; 108: 15792\u201315797.","DOI":"10.1073\/pnas.1111331108"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52 Shiroto T, Romero N, Sugiyama T, et al. Caveolin-1 is a critical determinant of autophagy, metabolic switching, and oxidative stress in vascular endothelium. PLoS One 2014; 9: e87871.","DOI":"10.1371\/journal.pone.0087871"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53 Lobysheva I, Rath G, Sekkali B, et al. Moderate caveolin-1 downregulation prevents NADPH oxidase-dependent endothelial nitric oxide synthase uncoupling by angiotensin II in endothelial cells. Arterioscler Thromb Vasc Biol 2011; 31: 2098\u20132105.","DOI":"10.1161\/ATVBAHA.111.230623"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54 Burgoyne JR, Madhani M, Cuello F, et al. Cysteine redox sensor in PKGIa enables oxidant-induced activation. Science 2007; 317: 1393\u20131397.","DOI":"10.1126\/science.1144318"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55 Chidgey J, Fraser PA, Aaronson PI. Reactive oxygen species facilitate the EDH response in arterioles by potentiating intracellular endothelial Ca<sup>2+<\/sup> release. Free Rad Biol Med 2016; 97: 274\u2013284.","DOI":"10.1016\/j.freeradbiomed.2016.06.010"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56 Zhang DX, Borbouse L, Gebremedhin D, et al. H<sub>2<\/sub>O<sub>2<\/sub>-induced dilation in human coronary arterioles: role of protein kinase G dimerization and large-conductance Ca<sup>2+<\/sup>-activated K<sup>+<\/sup> channel activation. Circ Res 2012; 110: 471\u2013480.","DOI":"10.1161\/CIRCRESAHA.111.258871"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57 Dou D, Zheng X, Liu J, Xu X, Ye L, Gao Y. Hydrogen peroxide enhances vasodilatation by increasing dimerization of cGMP-dependent protein kinase type Ia. Circ J 2012; 76: 1792\u20131798.","DOI":"10.1253\/circj.CJ-11-1368"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58 Vanhoutte PM, Zhao Y, Xu A, Leung SW. Thirty years of saying NO: sources, fate, actions, and misfortunes of the endothelium-derived vasodilator mediator. Circ Res 2016; 119: 375\u2013396.","DOI":"10.1161\/CIRCRESAHA.116.306531"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59 Bauersachs J, Popp R, Hecker M, Sauer E, Fleming I, Busse R. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation 1996; 94: 3341\u20133347.","DOI":"10.1161\/01.CIR.94.12.3341"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60 Nishikawa Y, Stepp DW, Chilian WM. Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilation <i>in vivo<\/i>. Am J Physiol 2000; 279: H459\u2013H465.","DOI":"10.1152\/ajpheart.2000.279.2.H459"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61 Olmos L, Mombouli JV, Illiano S, Vanhoutte PM. cGMP mediates the desensitization to bradykinin in isolated canine coronary arteries. Am J Physiol 1995; 268 (2 Pt 2): H865\u2013H870.","DOI":"10.1152\/ajpheart.1995.268.2.H865"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62 Burgoyne JR, Prysyazhna O, Rudyk O, Eaton P. cGMP-dependent activation of protein kinase G precludes disulfide activation: implications for blood pressure control. Hypertension 2012; 60: 1301\u20131308.","DOI":"10.1161\/HYPERTENSIONAHA.112.198754"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63 Saito H, Godo S, Sato S, et al. Important role of endothelial caveolin-1 in the protective role of endothelium-dependent hyperpolarization against nitric oxide-mediated nitrative stress in microcirculation in mice. J Cardiovasc Pharmacol 2018; 71: 113\u2013126.","DOI":"10.1097\/FJC.0000000000000552"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64 Enkhjargal B, Godo S, Sawada A, et al. Endothelial AMP-activated protein kinase regulates blood pressure and coronary flow responses through hyperpolarization mechanism in mice. Arterioscler Thromb Vasc Biol 2014; 34: 1505\u20131513.","DOI":"10.1161\/ATVBAHA.114.303735"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65 Fleming I. Molecular mechanisms underlying the activation of eNOS. Pflugers Arch 2010; 459: 793\u2013806.","DOI":"10.1007\/s00424-009-0767-7"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66 Ikumi Y, Shiroto T, Godo S, et al. Important roles of endothelium-dependent hyperpolarization in coronary microcirculation and cardiac diastolic function in mice. J Cardiovasc Pharmacol 2020; 75: 31\u201340.","DOI":"10.1097\/FJC.0000000000000763"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67 Crea F, Lanza G, Camici P. Mechanisms of coronary microvascular dysfunction. In: Coronary Microvascular Dysfunction. Springer Milan, Italy 2014; 31\u201347.","DOI":"10.1007\/978-88-470-5367-0_2"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68 Chadderdon SM, Belcik JT, Bader L, et al. Temporal changes in skeletal muscle capillary responses and endothelial-derived vasodilators in obesity-related insulin resistance. Diabetes 2016; 65: 2249\u20132257.","DOI":"10.2337\/db15-1574"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69 Matsuzawa Y, Kwon TG, Lennon RJ, Lerman LO, Lerman A. Prognostic value of flow-mediated vasodilation in brachial artery and fingertip artery for cardiovascular events: a systematic review and meta-analysis. J Am Heart Assoc 2015; 4. pii: e002270.","DOI":"10.1161\/JAHA.115.002270"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70 Murthy VL, Naya M, Taqueti VR, et al. Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation 2014; 129: 2518\u20132527.","DOI":"10.1161\/CIRCULATIONAHA.113.008507"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71 Suda A, Takahashi J, Hao K, et al. Coronary functional abnormalities in patients with angina and non-obstructive coronary artery disease. J Am Coll Cardiol 2019; 74: 2350\u20132360.","DOI":"10.1016\/j.jacc.2019.08.1056"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72 Al-Lamee R, Thompson D, Dehbi HM, et al. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet 2018; 391: 31\u201340.","DOI":"10.1016\/S0140-6736(17)32714-9"},{"key":"73","unstructured":"73 Crea F, Bairey Merz CN, Beltrame JF, et al. The parallel tales of microvascular angina and heart failure with preserved ejection fraction: a paradigm shift. Eur Heart J 2016; 38: 473\u2013477."},{"key":"74","doi-asserted-by":"crossref","unstructured":"74 Dryer K, Gajjar M, Narang N, et al. Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction. Am J Physiol 2018; 314: H1033\u2013H1042.","DOI":"10.1152\/ajpheart.00680.2017"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75 Shah SJ, Lam CSP, Svedlund S, et al. Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF. Eur Heart J 2018; 39: 3439\u20133450.","DOI":"10.1093\/eurheartj\/ehy531"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76 Borlaug BA, Anstrom KJ, Lewis GD, et al. Effect of inorganic nitrite vs placebo on exercise capacity among patients with heart failure with preserved ejection fraction: the INDIE-HFpEF randomized clinical trial. JAMA 2018; 320: 1764\u20131773.","DOI":"10.1001\/jama.2018.14852"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77 Chennupati R, Meens MJ, Janssen BJ, et al. Deletion of endothelial arginase 1 does not improve vasomotor function in diabetic mice. Physiol Rep 2018; 6: e13717.","DOI":"10.14814\/phy2.13717"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78 Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 2007; 297: 842\u2013857.","DOI":"10.1001\/jama.297.8.842"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79 Satoh K, Godo S, Saito H, Enkhjargal S, Shimokawa H. Dual roles of vascular-derived reactive oxygen species\u2014With a special reference to hydrogen peroxide and cyclophilin A\u2014. J Mol Cell Cardiol 2014; 73: 50\u201356.","DOI":"10.1016\/j.yjmcc.2013.12.022"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80 Shimokawa H, Satoh K. Light and dark of reactive oxygen species for vascular function: 2014 ASVB (Asian Society of Vascular Biology). J Cardiovasc Pharmacol 2015; 65: 412\u2013418.","DOI":"10.1097\/FJC.0000000000000159"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81 Schiattarella GG, Altamirano F, Tong D, et al. Nitrosative stress drives heart failure with preserved ejection fraction. Nature 2019; 568: 351\u2013356.","DOI":"10.1038\/s41586-019-1100-z"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82 Fukata Y, Amano M, Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci 2001; 22: 32\u201339.","DOI":"10.1016\/S0165-6147(00)01596-0"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83 Takai Y, Sasaki T, Matozaki T. Small GTP-binding proteins. Physiol Rev 2001; 81: 153\u2013208.","DOI":"10.1152\/physrev.2001.81.1.153"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84 Rikitake Y, Liao JK. ROCKs as therapeutic targets in cardiovascular diseases. Expert Rev Cardiovasc Ther 2005; 3: 441\u2013451.","DOI":"10.1586\/14779072.3.3.441"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85 Shimokawa H, Takeshita A. Rho-kinase is an important therapeutic target in cardiovascular medicine. Arterioscler Thromb Vasc Biol 2005; 25: 1767\u20131775.","DOI":"10.1161\/01.ATV.0000176193.83629.c8"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86 Shimokawa H, Satoh K. 2015 ATVB Plenary Lecture: Translational research on Rho-kinase in cardiovascular medicine. Arterioscler Thromb Vasc Biol 2015; 35: 1756\u20131769.","DOI":"10.1161\/ATVBAHA.115.305353"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87 Shimokawa H, Sunamura K, Satoh K. RhoA\/Rho-kinase in the cardiovascular system. Circ Res 2016; 118: 352\u2013366.","DOI":"10.1161\/CIRCRESAHA.115.306532"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88 Bernards A. GAPs galore! A survey of putative Ras superfamily GTPase activating proteins in man and Drosophila. Biochim Biophys Acta 2003; 1603: 47\u201382.","DOI":"10.1016\/S0304-419X(02)00082-3"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89 Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature 1994; 372: 231\u2013236.","DOI":"10.1038\/372231a0"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90 Hirata K, Kikuchi A, Sasaki T, et al. Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction. J Biol Chem 1992; 267: 8719\u20138722.","DOI":"10.1016\/S0021-9258(19)50337-4"},{"key":"91","doi-asserted-by":"crossref","unstructured":"91 Gong MC, Iizuka K, Nixon G, et al. Role of guanine nucleotide-bindingproteins\u2014ras-family or trimeric proteins or both\u2014in Ca<sup>2+<\/sup> sensitization of smooth muscle. Proc Natl Acad Sci U S A 1996; 93: 1340\u20131345.","DOI":"10.1073\/pnas.93.3.1340"},{"key":"92","doi-asserted-by":"crossref","unstructured":"92 Nishioka T, Shohag MH, Amano M, Kaibuchi K. Developing novel methods to search for substrates of protein kinases such as Rho-kinase. Biochim Biophys Acta 2015; 1854 (10 Pt B): 1663\u20131666.","DOI":"10.1016\/j.bbapap.2015.03.001"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93 Coleman ML, Sahai EA, Yeo M, Bosch M, Dewar A, Olson MF. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat Cell Biol 2001; 3: 339\u2013345.","DOI":"10.1038\/35070009"},{"key":"94","doi-asserted-by":"crossref","unstructured":"94 Sebbagh M, Hamelin J, Bertoglio J, Solary E, Breard J. Direct cleavage of ROCK II by granzyme B induces target cell membrane blebbing in a caspase-independent manner. J Exp Med 2005; 201: 465\u2013471.","DOI":"10.1084\/jem.20031877"},{"key":"95","doi-asserted-by":"crossref","unstructured":"95 van Nieuw Amerongen GP, Beckers CM, Achekar ID, Zeeman S, Musters RJ, van Hinsbergh VW. Involvement of Rho-kinases in endothelial barrier maintenance. Arterioscler Thromb Vasc Biol 2007; 27: 2332\u20132339.","DOI":"10.1161\/ATVBAHA.107.152322"},{"key":"96","doi-asserted-by":"crossref","unstructured":"96 Bell RD, Winkler EA, Singh I, et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 2012; 485: 512\u2013516.","DOI":"10.1038\/nature11087"},{"key":"97","doi-asserted-by":"crossref","unstructured":"97 Berk BC. Atheroprotective signaling mechanisms activated by steady laminar flow in endothelial cells. Circulation 2008; 117: 1082\u20131089.","DOI":"10.1161\/CIRCULATIONAHA.107.720730"},{"key":"98","doi-asserted-by":"crossref","unstructured":"98 Nigro P, Abe J, Berk BC. Flow shear stress and atherosclerosis: a matter of site specificity. Antioxid Redox Signal 2011; 15: 1405\u20131414.","DOI":"10.1089\/ars.2010.3679"},{"key":"99","doi-asserted-by":"crossref","unstructured":"99 Zhou Q, Liao JK. Rho-kinases: an important mediator of atherosclerosis and vascular disease. Curr Pharm Des 2009; 15: 3108\u20133115.","DOI":"10.2174\/138161209789057986"},{"key":"100","doi-asserted-by":"crossref","unstructured":"100 Yao L, Chandra S, Toque HA, et al. Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho-kinases (ROCK) knockout. Cardiovasc Res 2013; 97: 509\u2013519.","DOI":"10.1093\/cvr\/cvs371"},{"key":"101","doi-asserted-by":"crossref","unstructured":"101 Noda K, Godo S, Saito H, Tsutsui M, Shimokawa H. Opposing roles of nitric oxide and Rho-kinase in lipid metabolism in mice. Tohoku J ExpMed 2015; 235: 171\u2013183.","DOI":"10.1620\/tjem.235.171"},{"key":"102","doi-asserted-by":"crossref","unstructured":"102 Noda K, Nakajima S, Godo S, et al. Rho-kinase inhibition ameliorates metabolic disorders through activation of AMPK pathway in mice. PLoS One 2014; 9: e110446.","DOI":"10.1371\/journal.pone.0110446"},{"key":"103","doi-asserted-by":"crossref","unstructured":"103 Begum N, Sandu OA, Ito M, Lohmann SM, Smolenski A. Active Rho kinase (ROK-\u03b1) associates with insulin receptor substrate-1 and inhibits insulin signaling in vascular smooth muscle cells. J Biol Chem 2002; 277: 6214\u20136222.","DOI":"10.1074\/jbc.M110508200"},{"key":"104","doi-asserted-by":"crossref","unstructured":"104 Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol 2001; 21: 1712\u20131719.","DOI":"10.1161\/hq1101.098486"},{"key":"105","doi-asserted-by":"crossref","unstructured":"105 Takemoto M, Sun J, Hiroki J, Shimokawa H, Liao JK. Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase. Circulation 2002; 106: 57\u201362.","DOI":"10.1161\/01.CIR.0000020682.73694.AB"},{"key":"106","doi-asserted-by":"crossref","unstructured":"106 Tanaka S, Fukumoto Y, Nochioka K, et al. Statins exert the pleiotropic effects through small GTP-binding protein dissociation stimulator upregulation with a resultant Rac1 degradation. Arterioscler Thromb Vasc Biol 2013; 33: 1591\u20131600.","DOI":"10.1161\/ATVBAHA.112.300922"},{"key":"107","doi-asserted-by":"crossref","unstructured":"107 Shao D, Oka S, Brady CD, Haendeler J, Eaton P, Sadoshima J. Redox modification of cell signaling in the cardiovascular system. J Mol Cell Cardiol 2012; 52: 550\u2013558.","DOI":"10.1016\/j.yjmcc.2011.09.009"},{"key":"108","doi-asserted-by":"crossref","unstructured":"108 Higashi M, Shimokawa H, Hattori T, et al. Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats <i>in vivo<\/i>: effect on endothelial NAD(P)H oxidase system. Circ Res 2003; 93: 767\u2013775.","DOI":"10.1161\/01.RES.0000096650.91688.28"},{"key":"109","doi-asserted-by":"crossref","unstructured":"109 Hattori T, Shimokawa H, Higashi M, et al. Long-term treatment with a specific Rho-kinase inhibitor suppresses cardiac allograft vasculopathy in mice. Circ Res 2004; 94: 46\u201352.","DOI":"10.1161\/01.RES.0000107196.21335.2B"},{"key":"110","doi-asserted-by":"crossref","unstructured":"110 Funakoshi Y, Ichiki T, Shimokawa H, et al. Rho-kinase mediates angiotensin II-induced monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cells. Hypertension 2001; 38: 100\u2013104.","DOI":"10.1161\/01.HYP.38.1.100"},{"key":"111","doi-asserted-by":"crossref","unstructured":"111 Takeda K, Ichiki T, Tokunou T, et al. Critical role of Rho-kinase and MEK\/ERK pathways for angiotensin II-induced plasminogen activator inhibitor type-1 gene expression. Arterioscler Thromb Vasc Biol 2001; 21: 868\u2013873.","DOI":"10.1161\/01.ATV.21.5.868"},{"key":"112","doi-asserted-by":"crossref","unstructured":"112 Ohnaka K, Shimoda S, Nawata H, et al. Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts. Biochem Biophys Res Commun 2001; 287: 337\u2013342.","DOI":"10.1006\/bbrc.2001.5597"},{"key":"113","doi-asserted-by":"crossref","unstructured":"113 Cohen RA, Adachi T. Nitric-oxide-induced vasodilatation: regulation by physiologic s-glutathiolation and pathologic oxidation of the sarcoplasmic endoplasmic reticulum calcium ATPase. Trends Cardiovasc Med 2006; 16: 109\u2013114.","DOI":"10.1016\/j.tcm.2006.02.001"},{"key":"114","doi-asserted-by":"crossref","unstructured":"114 Wu C, Parrott AM, Fu C, et al. Thioredoxin 1-mediated post-translational modifications: reduction, transnitrosylation, denitrosylation, and related proteomics methodologies. Antioxid Redox Signal 2011; 15: 2565\u20132604.","DOI":"10.1089\/ars.2010.3831"}],"container-title":["Journal of Clinical Biochemistry and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/66\/2\/66_19-119\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T10:51:13Z","timestamp":1614423073000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/66\/2\/66_19-119\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":114,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.3164\/jcbn.19-119","relation":{},"ISSN":["0912-0009","1880-5086"],"issn-type":[{"value":"0912-0009","type":"print"},{"value":"1880-5086","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,1]]}}}